Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 -9.50 (-0.50%)

Bid:

1,904.00

Ask:

1,905.00

Spread: 1.00 (0.053%)

Market Cap: £76.34b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

London close: Stocks slide in global reaction to Trump tariffs

(Sharecast News) - London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly agg...

UK dividends calendar - next 7 days

UK pharma stocks avoid selloff

(Sharecast News) - GSK and AstraZeneca avoided the selloff on Thursday as pharmaceutical products were exempt from Donald's Trump's tariffs.

LONDON MARKET MIDDAY: Stocks struggle as "liberation day" tariffs loom

(Alliance News) - European stocks were lower on Wednesday afternoon, as investors moved with trepidation ahead of an announcement on reciprocal US tar...

LONDON MARKET MIDDAY: Stocks rise in calm before tariff storm

(Alliance News) - Stock prices in London were higher at midday on Tuesday despite investors bracing themselves for Wednesday's fresh wave of tariffs f...

IN BRIEF: Haleon initiates first tranche of GBP330 million buyback

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - Commences up to GBP330 million share buyback programm...

GSK urinary tract infection drug Blujepa approved by US regulator

(Alliance News) - GSK on Tuesday said its urinary tract infection treatment gepotidacin, under the brand name Blujepa, has been approved in the US.

GSK has application to expand use of mepolizumab accepted by EMA

(Alliance News) - GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstructive pulmonary...